“…We also synthesized naphthofuro[3,2- c ]quinoline-6,7,12-trione VI, and pyrano[3,2- c ]quinoline-6,7,8,13-tetraone, VII that have shown potential as ERK inhibitors [32] , whereas synthesis of bis(6-substituted-4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)naphtha-ene-1,4-dione VIII and (substituted N -(alkyl)bis-quinolinone)-triethylammonium salt VIV [33] , were explored as candidates for extracellular signal-regulated kinases 1/2 (ERK1/2) having antineoplastic activity [33] . Recently, we have reported the synthesis of 5,12-dihydro-pyrazino[2,3- c :5,6- c' ]difuro[2,3- c :4,5- c' ]-diquinoline-6,14( 5 H,12 H )-dione X [34] and 2-(4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)-1,4-diphenyl-butane-1,4-dione XI [34] . Most indicative is our recent synthesis of 6-substiuted-4-(2-(4-substituted-benzylidene)hydrazinyl)quinolin-2(1H)-one derivative XII [35] which was evaluated for their in vitro cytotoxic activity against 60 cancer cell lines according to NCI protocol [35] .…”